117 related articles for article (PubMed ID: 20076883)
1. Immunohistochemical expression of HER-2/NEU-CERBB-2 in patients with adenocarcinoma of the stomach.
Cirne-Lima FK; Rosa Ade S; Kulczynski JM; Mattana DS; Corezolla K; Moreira LF
Rev Col Bras Cir; 2009 Apr; 36(2):131-4. PubMed ID: 20076883
[TBL] [Abstract][Full Text] [Related]
2. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.
Yan SY; Hu Y; Fan JG; Tao GQ; Lu YM; Cai X; Yu BH; Du YQ
World J Gastroenterol; 2011 Mar; 17(11):1501-6. PubMed ID: 21472111
[TBL] [Abstract][Full Text] [Related]
4. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
Kono K; Naganuma H; Sekikawa T; Amemiya H; Takahashi A; Iizuka H; Matsumoto Y
Tumour Biol; 2000; 21(3):139-44. PubMed ID: 10754464
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.
Chiu KY; Loke SL; Ho FC
J Clin Pathol; 1994 Feb; 47(2):117-21. PubMed ID: 7907612
[TBL] [Abstract][Full Text] [Related]
6. HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
Liu W; Zhong S; Chen J; Yu Y
J Clin Gastroenterol; 2012 Apr; 46(4):e31-7. PubMed ID: 22064554
[TBL] [Abstract][Full Text] [Related]
7. HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana.
Simpong DL; Asmah RH; Krampah C; Akakpo PK; Adu P; Asante DB; Naporo S; Adjei AA; Gyasi RK
ScientificWorldJournal; 2018; 2018():1564150. PubMed ID: 29725274
[TBL] [Abstract][Full Text] [Related]
8. [Expression of the cerbB-2 (HER-2/neu) oncoprotein in prostatic adenocarcinoma].
San Miguel Fraile P; Dos Santos JE; Pélaez Boismorand E; Ortiz Rey JA; Iglesias Rodríguez B; Cambronero Santos J; Fajardo Seijo JL; Rodríguez Costas JM; Fernández Regueiro M
Actas Urol Esp; 2005 Jan; 29(1):64-9. PubMed ID: 15786765
[TBL] [Abstract][Full Text] [Related]
9. Incidence of brain metastases in HER2+ gastric or gastroesophageal junction adenocarcinoma.
Blay C; Chiforeanu DC; Boucher E; Cabillic F; Desgrippes R; Leconte B; Perrin C; Manfredi S; Audrain O; Meunier B; Edeline J
Acta Oncol; 2015 Nov; 54(10):1833-5. PubMed ID: 25753188
[No Abstract] [Full Text] [Related]
10. [Association of HER-2/neu expression with prognosis of gastric cancer].
Chen B; Luo RC; Cui F; Qian XY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):344-7. PubMed ID: 16546744
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms.
Day JD; Digiuseppe JA; Yeo C; Lai-Goldman M; Anderson SM; Goodman SN; Kern SE; Hruban RH
Hum Pathol; 1996 Feb; 27(2):119-24. PubMed ID: 8617452
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.
Shabbir A; Mirza T; Khalid AB; Qureshi MA; Asim SA
BMC Cancer; 2016 Nov; 16(1):855. PubMed ID: 27821098
[TBL] [Abstract][Full Text] [Related]
13. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu amplification and overexpression in endometrial carcinoma.
Rolitsky CD; Theil KS; McGaughy VR; Copeland LJ; Niemann TH
Int J Gynecol Pathol; 1999 Apr; 18(2):138-43. PubMed ID: 10202671
[TBL] [Abstract][Full Text] [Related]
15. Relationship between HER-2, COX-2, p53 and clinicopathologic features in gastric adenocarcinoma. Do these biomarkers have any prognostic significance?
Ugraş N; Özgün G; Ocakoğlu G; Yerci Ö; Öztürk E
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():176-81. PubMed ID: 25910300
[TBL] [Abstract][Full Text] [Related]
16. The differential expression of the HER-2/neu oncogene among high-risk human papillomavirus-infected glandular lesions of the uterine cervix.
Roland PY; Stoler MH; Broker TR; Chow LT
Am J Obstet Gynecol; 1997 Jul; 177(1):133-8. PubMed ID: 9240596
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Human Epidermal Growth Factor Receptor 2 (Her2/Neu) Expression in Gastric Adenocarcinoma in Rehman Medical Institute Peshawar.
Khattak MT; Hassan M; Nasib B; Qamar MA; Javed S; Ali N
J Pak Med Assoc; 2019 Jun; 69(6):788-793. PubMed ID: 31189283
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma.
Tawfik OW; Kimler BF; Davis M; Donahue JK; Persons DL; Fan F; Hagemeister S; Thomas P; Connor C; Jewell W; Fabian CJ
Histopathology; 2006 Feb; 48(3):258-67. PubMed ID: 16430472
[TBL] [Abstract][Full Text] [Related]
19. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
[TBL] [Abstract][Full Text] [Related]
20. Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population.
Shabbir A; Qureshi MA; Khalid AB; Mirza T; Shaikh A; Hasan SM
Saudi J Gastroenterol; 2018; 24(5):289-293. PubMed ID: 29806596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
